Articles related to OFF-LABEL USE

Adjunctive low-dose naltrexone did not separate from placebo on depressive symptom reduction in a 38-patient randomized trial of adults with moderate major depressive disorder on existing antidepressants.

A pediatric gastroenterology expert outlines when extrapolation of adult IBD therapies to children is reasonable, where it falls short, and how shared decision-making should be structured.

Patients seeking ketamine treatment have often spent years seeking to treat their mental health symptoms, and out of that desperation, seek out care without thoroughly vetting their options or practitioners.

Less than half of people prescribed gabapentin will not notice meaningful pain relief but will likely experience side effects or adverse events.

Multiple oncologists report anecdotal success with antiparasitic protocols, citing at least 12 potential anticancer mechanisms while acknowledging the absence of human clinical trials and FDA approval for cancer treatment.

Nearly 20 million viewers watched content suggesting antiparasitic drugs cured stage IV cancer, prompting widespread patient inquiries despite absence of human efficacy data.